Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of α-synuclein: Implications for the pathogenesis of Parkinson disease

Adrien W. Schmid, Diego Chiappe, Vérène Pignat, Valerie Grimminger, Ivan Hang, Marc Moniatte, Hilal A. Lashuel

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Tissue transglutaminase (tTG) has been implicated in the pathogenesis of Parkinson disease (PD). However, exactly how tTG modulates the structural and functional properties of α-synuclein (α-syn) and contributes to the pathogenesis of PD remains unknown. Using site-directed mutagenesis combined with detailed biophysical and mass spectrometry analyses, we sought to identify the exact residues involved in tTG-catalyzed cross-linking of wild-type α-syn and α-syn mutants associated with PD. To better understand the structural consequences of each cross-linking reaction, we determined the effect of tTG-catalyzed cross-linking on the oligomerization, fibrillization, and membrane binding of α-syn in vitro. Our findings show that tTG-catalyzed cross-linking of monomeric α-syn involves multiple cross-links (specifically 2-3). We subjected tTG-catalyzed cross-linked monomeric α-syn composed of either wild-type or Gln → Asn mutants to sequential proteolysis by multiple enzymes and peptide mapping by mass spectrometry. Using this approach, we identified the glutamine and lysine residues involved in tTG-catalyzed intramolecular cross-linking of α-syn. These studies demonstrate for the first time that Gln79 and Gln109 serve as the primary tTG reactive sites. Mutating both residues to asparagine abolishes tTG-catalyzed cross-linking of α-syn and tTG-induced inhibition of α-syn fibrillization in vitro. To further elucidate the sequence and structural basis underlying these effects, we identified the lysine residues that form isopeptide bonds with Gln79 and Gln109. This study provides mechanistic insight into the sequence and structural basis of the inhibitory effects of tTG on α-syn fibrillogenesis in vivo, and it sheds light on the potential role of tTG cross-linking on modulating the physiological and pathogenic properties of α-syn.

Original languageEnglish
Pages (from-to)13128-13142
Number of pages15
JournalJournal of Biological Chemistry
Volume284
Issue number19
DOIs
Publication statusPublished - 8 May 2009
Externally publishedYes

Fingerprint

Synucleins
Parkinson Disease
Lysine
Mass spectrometry
transglutaminase 2
Mass Spectrometry
Proteolysis
Oligomerization
Mutagenesis
Peptide Mapping
Asparagine
Cross Reactions
Site-Directed Mutagenesis
Glutamine

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of α-synuclein : Implications for the pathogenesis of Parkinson disease. / Schmid, Adrien W.; Chiappe, Diego; Pignat, Vérène; Grimminger, Valerie; Hang, Ivan; Moniatte, Marc; Lashuel, Hilal A.

In: Journal of Biological Chemistry, Vol. 284, No. 19, 08.05.2009, p. 13128-13142.

Research output: Contribution to journalArticle

Schmid, Adrien W. ; Chiappe, Diego ; Pignat, Vérène ; Grimminger, Valerie ; Hang, Ivan ; Moniatte, Marc ; Lashuel, Hilal A. / Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of α-synuclein : Implications for the pathogenesis of Parkinson disease. In: Journal of Biological Chemistry. 2009 ; Vol. 284, No. 19. pp. 13128-13142.
@article{d447a116aeaa450881cc74a73acddf74,
title = "Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of α-synuclein: Implications for the pathogenesis of Parkinson disease",
abstract = "Tissue transglutaminase (tTG) has been implicated in the pathogenesis of Parkinson disease (PD). However, exactly how tTG modulates the structural and functional properties of α-synuclein (α-syn) and contributes to the pathogenesis of PD remains unknown. Using site-directed mutagenesis combined with detailed biophysical and mass spectrometry analyses, we sought to identify the exact residues involved in tTG-catalyzed cross-linking of wild-type α-syn and α-syn mutants associated with PD. To better understand the structural consequences of each cross-linking reaction, we determined the effect of tTG-catalyzed cross-linking on the oligomerization, fibrillization, and membrane binding of α-syn in vitro. Our findings show that tTG-catalyzed cross-linking of monomeric α-syn involves multiple cross-links (specifically 2-3). We subjected tTG-catalyzed cross-linked monomeric α-syn composed of either wild-type or Gln → Asn mutants to sequential proteolysis by multiple enzymes and peptide mapping by mass spectrometry. Using this approach, we identified the glutamine and lysine residues involved in tTG-catalyzed intramolecular cross-linking of α-syn. These studies demonstrate for the first time that Gln79 and Gln109 serve as the primary tTG reactive sites. Mutating both residues to asparagine abolishes tTG-catalyzed cross-linking of α-syn and tTG-induced inhibition of α-syn fibrillization in vitro. To further elucidate the sequence and structural basis underlying these effects, we identified the lysine residues that form isopeptide bonds with Gln79 and Gln109. This study provides mechanistic insight into the sequence and structural basis of the inhibitory effects of tTG on α-syn fibrillogenesis in vivo, and it sheds light on the potential role of tTG cross-linking on modulating the physiological and pathogenic properties of α-syn.",
author = "Schmid, {Adrien W.} and Diego Chiappe and V{\'e}r{\`e}ne Pignat and Valerie Grimminger and Ivan Hang and Marc Moniatte and Lashuel, {Hilal A.}",
year = "2009",
month = "5",
day = "8",
doi = "10.1074/jbc.M809067200",
language = "English",
volume = "284",
pages = "13128--13142",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "19",

}

TY - JOUR

T1 - Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of α-synuclein

T2 - Implications for the pathogenesis of Parkinson disease

AU - Schmid, Adrien W.

AU - Chiappe, Diego

AU - Pignat, Vérène

AU - Grimminger, Valerie

AU - Hang, Ivan

AU - Moniatte, Marc

AU - Lashuel, Hilal A.

PY - 2009/5/8

Y1 - 2009/5/8

N2 - Tissue transglutaminase (tTG) has been implicated in the pathogenesis of Parkinson disease (PD). However, exactly how tTG modulates the structural and functional properties of α-synuclein (α-syn) and contributes to the pathogenesis of PD remains unknown. Using site-directed mutagenesis combined with detailed biophysical and mass spectrometry analyses, we sought to identify the exact residues involved in tTG-catalyzed cross-linking of wild-type α-syn and α-syn mutants associated with PD. To better understand the structural consequences of each cross-linking reaction, we determined the effect of tTG-catalyzed cross-linking on the oligomerization, fibrillization, and membrane binding of α-syn in vitro. Our findings show that tTG-catalyzed cross-linking of monomeric α-syn involves multiple cross-links (specifically 2-3). We subjected tTG-catalyzed cross-linked monomeric α-syn composed of either wild-type or Gln → Asn mutants to sequential proteolysis by multiple enzymes and peptide mapping by mass spectrometry. Using this approach, we identified the glutamine and lysine residues involved in tTG-catalyzed intramolecular cross-linking of α-syn. These studies demonstrate for the first time that Gln79 and Gln109 serve as the primary tTG reactive sites. Mutating both residues to asparagine abolishes tTG-catalyzed cross-linking of α-syn and tTG-induced inhibition of α-syn fibrillization in vitro. To further elucidate the sequence and structural basis underlying these effects, we identified the lysine residues that form isopeptide bonds with Gln79 and Gln109. This study provides mechanistic insight into the sequence and structural basis of the inhibitory effects of tTG on α-syn fibrillogenesis in vivo, and it sheds light on the potential role of tTG cross-linking on modulating the physiological and pathogenic properties of α-syn.

AB - Tissue transglutaminase (tTG) has been implicated in the pathogenesis of Parkinson disease (PD). However, exactly how tTG modulates the structural and functional properties of α-synuclein (α-syn) and contributes to the pathogenesis of PD remains unknown. Using site-directed mutagenesis combined with detailed biophysical and mass spectrometry analyses, we sought to identify the exact residues involved in tTG-catalyzed cross-linking of wild-type α-syn and α-syn mutants associated with PD. To better understand the structural consequences of each cross-linking reaction, we determined the effect of tTG-catalyzed cross-linking on the oligomerization, fibrillization, and membrane binding of α-syn in vitro. Our findings show that tTG-catalyzed cross-linking of monomeric α-syn involves multiple cross-links (specifically 2-3). We subjected tTG-catalyzed cross-linked monomeric α-syn composed of either wild-type or Gln → Asn mutants to sequential proteolysis by multiple enzymes and peptide mapping by mass spectrometry. Using this approach, we identified the glutamine and lysine residues involved in tTG-catalyzed intramolecular cross-linking of α-syn. These studies demonstrate for the first time that Gln79 and Gln109 serve as the primary tTG reactive sites. Mutating both residues to asparagine abolishes tTG-catalyzed cross-linking of α-syn and tTG-induced inhibition of α-syn fibrillization in vitro. To further elucidate the sequence and structural basis underlying these effects, we identified the lysine residues that form isopeptide bonds with Gln79 and Gln109. This study provides mechanistic insight into the sequence and structural basis of the inhibitory effects of tTG on α-syn fibrillogenesis in vivo, and it sheds light on the potential role of tTG cross-linking on modulating the physiological and pathogenic properties of α-syn.

UR - http://www.scopus.com/inward/record.url?scp=67349196431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349196431&partnerID=8YFLogxK

U2 - 10.1074/jbc.M809067200

DO - 10.1074/jbc.M809067200

M3 - Article

C2 - 19164286

AN - SCOPUS:67349196431

VL - 284

SP - 13128

EP - 13142

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 19

ER -